These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3558864)

  • 1. Prospective evaluation of prognostic value of morphometry in patients with primary breast cancer.
    van der Linden JC; Baak JP; Lindeman J; Hermans J; Meyer CJ
    J Clin Pathol; 1987 Mar; 40(3):302-6. PubMed ID: 3558864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphometry and breast cancer. II. Characterisation of breast cancer cells with high malignant potential in patients with spread to lymph nodes: preliminary results.
    van der Linden HC; Baak JP; Lindeman J; Hermans J; Meyer CJ
    J Clin Pathol; 1986 Jun; 39(6):603-9. PubMed ID: 3722413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
    Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
    J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.
    Janssen EA; Baak JP; Guervós MA; van Diest PJ; Jiwa M; Hermsen MA
    J Pathol; 2003 Dec; 201(4):555-61. PubMed ID: 14648658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of morphometry to classic prognosticators in breast cancer.
    Baak JP; Van Dop H; Kurver PH; Hermans J
    Cancer; 1985 Jul; 56(2):374-82. PubMed ID: 4005802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
    Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
    Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of extracapsular extension of axillary lymph node metastases in T1 to T3 breast cancer.
    Neri A; Marrelli D; Roviello F; De Stefano A; Guarnieri A; Pallucca E; Pinto E
    Ann Surg Oncol; 2005 Mar; 12(3):246-53. PubMed ID: 15827817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative histopathology in lymph node-negative breast cancer. Prognostic significance of mitotic counts.
    Ladekarl M; Jensen V
    Virchows Arch; 1995; 427(3):265-70. PubMed ID: 7496595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of nodal ratio on breast cancer recurrence and its potential for incorporation in a new prognostic index.
    Martin FT; O'Fearraigh C; Hanley C; Curran C; Sweeney KJ; Kerin MJ
    Breast J; 2013; 19(4):388-93. PubMed ID: 23721403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of axillary lymph node status on the prognosis of patients with local-regional recurrence after breast-conserving surgery].
    Zhang Z; Zhang W; Li ZJ; Wang XM; Cao XC; Xiao CH
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):347-351. PubMed ID: 29860761
    [No Abstract]   [Full Text] [Related]  

  • 13. Oestrogen receptors and primary breast cancer.
    Humeniuk V; Hawkins RA; Prescott RJ; Roberts MM; Stewart HJ; Forrest AP
    Aust N Z J Surg; 1982 Aug; 52(4):408-14. PubMed ID: 6956318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer.
    Yamashita H; Ogiya A; Shien T; Horimoto Y; Masuda N; Inao T; Osako T; Takahashi M; Endo Y; Hosoda M; Ishida N; Horii R; Yamazaki K; Miyoshi Y; Yasojima H; Tomioka N;
    Breast Cancer; 2016 Nov; 23(6):830-843. PubMed ID: 26467036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node-negative breast cancer patients younger than 55 years.
    Baak JP; van Diest PJ; Voorhorst FJ; van der Wall E; Beex LV; Vermorken JB; Janssen EA
    J Clin Oncol; 2005 Sep; 23(25):5993-6001. PubMed ID: 16135467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new perspective on axillary dissection in situations of metastatic sentinel node].
    Zedníková I; Ňaršanská A; Hes O; Metelková A; Fiala O; Svoboda T
    Rozhl Chir; 2017; 96(8):346-352. PubMed ID: 29058925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proliferation index and its prognostic value in invasive ductal breast carcinoma].
    Falco M
    Ann Acad Med Stetin; 2009; 55(1):22-30. PubMed ID: 20349588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Breast Cancer Index for Prediction of Distant Recurrence in HR
    Zhang Y; Schroeder BE; Jerevall PL; Ly A; Nolan H; Schnabel CA; Sgroi DC
    Clin Cancer Res; 2017 Dec; 23(23):7217-7224. PubMed ID: 28939745
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative predictive value of three prognostic markers--S-phase fraction, PCNA and Mitotic count on axillary lymph node metastasis in carcinoma breast.
    Pervez S; Khan MN; Nasir MI
    J Ayub Med Coll Abbottabad; 2007; 19(1):3-5. PubMed ID: 17867469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The morphometric prognostic index is the strongest prognosticator in premenopausal lymph node-negative and lymph node-positive breast cancer patients.
    van Diest PJ; Baak JP
    Hum Pathol; 1991 Apr; 22(4):326-30. PubMed ID: 2050366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.